Neil Horowitz

Neil Horowitz

UNVERIFIED PROFILE

Are you Neil Horowitz?   Register this Author

Register author
Neil Horowitz

Neil Horowitz

Publications by authors named "Neil Horowitz"

Are you Neil Horowitz?   Register this Author

100Publications

2201Reads

16Profile Views

Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer.

Gynecol Oncol 2019 06 29;153(3):471-478. Epub 2019 Mar 29.

Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.247DOI Listing
June 2019

Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).

Int J Gynecol Pathol 2019 May;38(3):230-240

Department of Pathology, Women's and Perinatal Pathology Division (H.M.D., K.C.S., E.E.M., W.R.W., M.S.H., B.J.Q., K.R.L., C.P.C., G.L.M., M.R.N., B.E.H.) Division of Gynecologic Oncology and Reproductive Biology (M.G.M., J.F.L., C.F., N.H., R.S.B.), Brigham and Women's Hospital Department of Pathology, Beth Israel Deaconess Medical Center (M.G., J.L.H., D.I.L.) Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute (E.S., P.A.K., U.A.M.), Harvard Medical School, Boston, Massachusetts Department of Pathology, Duke University Medical Center, Durham, North Carolina (K.C.S.) Department of Gynecology and Obstetrics, Odense University Hospital, University of Southern Denmark, Odense, Denmark (K.M.J.) Department of Pathology, Stanford University, Stanford, California (B.E.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000513DOI Listing
May 2019

Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?

Gynecol Oncol 2019 05 8;153(2):277-285. Epub 2019 Mar 8.

New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.005DOI Listing
May 2019

A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.

Am J Obstet Gynecol 2019 May 10. Epub 2019 May 10.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2019.05.006DOI Listing
May 2019

Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?

Gynecol Oncol 2019 04 8;153(1):63-67. Epub 2019 Jan 8.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258193000
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2019.01.001DOI Listing
April 2019

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.

Gynecol Oncol 2019 04 18;153(1):74-79. Epub 2019 Jan 18.

Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.01.016DOI Listing
April 2019

Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.

Int J Gynecol Cancer 2019 03;29(3):585-592

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Harvard Medical School, Dana Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2018-000154DOI Listing
March 2019

The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.

Gynecol Oncol 2019 02 30;152(2):426-433. Epub 2018 Nov 30.

Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA 02115, United States of America. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183145
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.11.033DOI Listing
February 2019

A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.

Curr Probl Cancer 2019 Feb 7. Epub 2019 Feb 7.

Brigham and Women's Hospital, Department of Gynecologic Oncology, Boston, Massachusetts; Dana Farber Cancer Institute, Department of Gynecologic Oncology, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2019.01.006DOI Listing
February 2019

Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.

J Pathol 2018 Nov 27;246(3):344-351. Epub 2018 Sep 27.

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5145DOI Listing
November 2018

Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?

Gynecol Oncol 2018 08 20;150(2):233-238. Epub 2018 Jun 20.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.06.015DOI Listing
August 2018

The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.

Gynecol Oncol 2018 07 9;150(1):67-72. Epub 2018 May 9.

Division of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.05.002DOI Listing
July 2018

In Reply.

Obstet Gynecol 2018 07;132(1):218

Rio de Janeiro Federal University and Fluminense Federal University, Rio de Janeiro, Brazil São Paulo Federal University, São Paulo, Brazil Central University of Venezuela, Caracas, Venezuela São Paulo State University, São Paulo, Brazil Harvard Medical School, Boston, Massachusetts Rio de Janeiro Federal University and Fluminense Federal University, Rio de Janeiro, Brazil Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000002720DOI Listing
July 2018

Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy.

Obstet Gynecol 2018 04;131(4):652-659

Rio de Janeiro Trophoblastic Disease Center, the Postgraduate Program of Medical Sciences of Fluminense Federal University, and the Postgraduate Program in Perinatal Health of Maternity School of Rio de Janeiro Federal University, Rio de Janeiro, Brazil São Paulo Hospital of São Paulo Federal University, São Paulo, Brazil; Caracas University Hospital of Central University of Venezuela, Caracas, Venezuela; Botucatu Trophoblastic Disease Center, Department of Gynecology and Obstetrics, Botucatu Medical School, São Paulo State University, São Paulo, Brazil; and the New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00006250-201804000-0000
Publisher Site
http://dx.doi.org/10.1097/AOG.0000000000002522DOI Listing
April 2018

Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?

Gynecol Oncol 2018 02 13;148(2):239-246. Epub 2017 Dec 13.

New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.12.007DOI Listing
February 2018

Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.

Gynecol Oncol 2018 01 29;148(1):161-167. Epub 2017 Oct 29.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Donald P. Goldstein M.D. Tumor Registry, Boston, MA, USA; Dana Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.10.028DOI Listing
January 2018

Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute.

Gynecol Oncol 2018 01 6;148(1):5-11. Epub 2017 Dec 6.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States; New England Trophoblastic Disease Center, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.11.029DOI Listing
January 2018

A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors.

Obesity (Silver Spring) 2017 11;25 Suppl 2:S102-S108

Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/oby.22021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743497PMC
November 2017

Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study.

Gynecol Oncol 2017 07 4;146(1):69-73. Epub 2017 May 4.

Division of Women's & Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258173079
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2017.04.015DOI Listing
July 2017

Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review.

Gynecol Oncol 2017 Apr 26;145(1):88-95. Epub 2017 Jan 26.

New England Trophoblastic Disease Center, Donald P. Goldstein MD, Trophoblastic Tumor Registry, Boston, MA, USA; Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA, USA; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA; Dana Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.01.021DOI Listing
April 2017

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.

Int J Gynecol Pathol 2017 Mar;36(2):115-127

Departments of Pathology (J.C.W., J.L.H., C.P.C, L.M.S., B.E.H.) Gynecologic Oncology (M.C.M., C.M.F., R.S.B., N.S.H.), Brigham And Women's Hospital Department of Medical Oncology (S.S., M.B.Y., A.C.), Dana-Farber Cancer Institute, Boston, MA Department of Pathology (E.J.Y.), Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000312DOI Listing
March 2017

Management and outcome of cervical cancer diagnosed in pregnancy.

Am J Obstet Gynecol 2017 03 31;216(3):276.e1-276.e6. Epub 2016 Oct 31.

Division of Maternal Fetal Medicine, Massachusetts General Hospital, Vincent Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2016.10.034DOI Listing
March 2017

Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities.

Gynecol Oncol 2017 Jan 24;144(1):208-214. Epub 2016 Oct 24.

New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA 02115, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.10.024DOI Listing
January 2017

Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age.

Gynecol Oncol 2016 10 30;143(1):73-76. Epub 2016 Jul 30.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, USA; Department of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School Boston, MA, USA; New England Trophoblastic Disease Center, Donald P. Goldstein, MD, Trophoblastic Tumor Registry, Boston, USA; Gynecologic Oncology Program, Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute/Harvard Cancer Center, Boston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.117DOI Listing
October 2016

Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.

Am J Obstet Gynecol 2016 09 26;215(3):334.e1-6. Epub 2016 Apr 26.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA; Gynecologic Oncology Program, Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute/Harvard Cancer Center, Boston, MA; New England Trophoblastic Disease Center, Donald P. Goldstein, MD, Trophoblastic Tumor Registry, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2016.04.019DOI Listing
September 2016

Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy.

Gynecol Oncol 2016 08 3;142(2):293-8. Epub 2016 Jun 3.

Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.05.019DOI Listing
August 2016

Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer.

Int J Gynecol Cancer 2016 07;26(6):1033-40

*Division of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, †Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; and ‡Saint Peter's University Hospital, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000729DOI Listing
July 2016

Optimal management of low-risk gestational trophoblastic neoplasia.

Expert Rev Anticancer Ther 2015 30;15(11):1293-304. Epub 2015 Oct 30.

a 1 The New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital; Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.2015.10
Publisher Site
http://dx.doi.org/10.1586/14737140.2015.1088786DOI Listing
June 2016

The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy.

Gynecol Oncol 2016 Mar 9;140(3):470-3. Epub 2016 Jan 9.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, USA; Gynecologic Oncology Program, Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute/Harvard Cancer Center, Boston, USA; New England Trophoblastic Disease Center, Donald P. Goldstein M.D., Trophoblastic Tumor Registry, Boston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.01.005DOI Listing
March 2016

Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.

Int J Gynecol Cancer 2016 Feb;26(2):367-70

*Department of Obstetrics and †Trophoblastic Disease Center of São Paulo Hospital, Paulista School of Medicine, UNIFESP-São Paulo Federal University, São Paulo, São Paulo, Brazil; and ‡Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital; §New England Trophoblastic Disease Center, Donald P. Goldstein, MD, Trophoblastic Tumor Registry; ∥Dana Farber Cancer Institute/Harvard Cancer Center; and ¶Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2016/02000/Clinical_Presen
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000608DOI Listing
February 2016

Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer.

Ann Surg Oncol 2016 Jan 9;23(1):178-85. Epub 2015 May 9.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4582-4DOI Listing
January 2016

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer.

Ann Surg Oncol 2015 Dec;22 Suppl 3:S1606-7

Surgical ICU Translational Research Center, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4401-yDOI Listing
December 2015

Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer.

Ann Surg Oncol 2015 Dec;22 Suppl 3:S1611

Surgical ICU Translational Research Center, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4542-zDOI Listing
December 2015

Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer.

Gynecol Oncol 2015 Dec 23;139(3):407-12. Epub 2015 Jul 23.

Division of Gynecologic Oncology, Ob/Gyn and Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.07.101DOI Listing
December 2015

Reply to G.D. Aletti et al.

J Clin Oncol 2015 Oct 24;33(30):3521-2. Epub 2015 Aug 24.

Innova Fairfax Women's Hospital, Falls Church, VA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.5707DOI Listing
October 2015

Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.

Cancer Chemother Pharmacol 2015 Aug 29;76(2):417-23. Epub 2015 Jun 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2813-9DOI Listing
August 2015

Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.

Gynecol Oncol 2015 Jul 12;138(1):201-6. Epub 2015 Apr 12.

Division of Medical Oncology, Dana Farber Cancer Institute, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469517PMC
July 2015

Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.

Gynecol Oncol 2015 Jul 28;138(1):50-4. Epub 2015 Apr 28.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, USA; New England Trophoblastic Disease Center, Donald P. Goldstein M.D. Tumor Registry, Boston, USA; Dana Farber Cancer Institute/Harvard Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.04.030DOI Listing
July 2015

Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?

Gynecol Oncol 2015 Jul 10;138(1):46-9. Epub 2015 May 10.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, USA; New England Trophoblastic Disease Center, Donald P. Goldstein, MD. Trophoblastic Tumor Registry, Boston, USA; Dana Farber Cancer Institute/Harvard Cancer Center, Boston, USA; Harvard Medical School, Boston, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.05.002DOI Listing
July 2015

Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.

Am J Obstet Gynecol 2015 May 13;212(5):600.e1-8. Epub 2014 Dec 13.

Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2014.12.013DOI Listing
May 2015

Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.

Int J Gynecol Cancer 2015 May;25(4):734-40

*Department of Gynecology and Obstetrics, and †Trophoblastic Diseases Center, Botucatu Medical School, UNESP-Sao Pãulo State University, Botucatu, Sao Pãulo, Brazil; ‡Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital; §New England Trophoblastic Disease Center, Donald P. Goldstein M.D. Tumor Registry; ∥Dana Farber Cancer Institute/Harvard Cancer Center; and ¶Harvard Medical School, Boston, MA; #Clinical Department, Caldas University, Manizales, Caldas, Colombia; and **Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000398DOI Listing
May 2015

Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer.

Ann Surg Oncol 2015 Apr 7;22(4):1341-8. Epub 2014 Oct 7.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-4112-9DOI Listing
April 2015

Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?

Gynecol Oncol 2015 Apr 8;137(1):60-5. Epub 2015 Feb 8.

Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medicine School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.02.001DOI Listing
April 2015

Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.

Am J Surg Pathol 2015 Mar;39(3):287-93

*Department of Pathology, Division of Women's and Perinatal Pathology §Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital ‡Dana Farber Cancer Institute, Boston MA †Department of Pathology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000369DOI Listing
March 2015

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.

J Clin Oncol 2015 Mar 9;33(8):937-43. Epub 2015 Feb 9.

Neil S. Horowitz, Brigham and Women's Hospital, Boston, MA; Austin Miller, Roswell Park Cancer Institute, Buffalo, NY; Bunja Rungruang, Georgia Regents University, Augusta, GA; Scott D. Richard, Hahnemann University Hospital, Philadelphia; Thomas C. Krivak, Western Pennsylvania Hospital, Pittsburgh, PA; Noah Rodriguez, Kaiser Permanente Irvine Medical Center, Irvine, CA; Michael A. Bookman, University of Arizona Cancer Center, Tucson, AZ; Chad A. Hamilton, Walter Reed National Military Medical Center, Bethesda, MD; and G. Larry Maxwell, Inova Fairfax Women's Hospital, Falls Church, VA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.3106
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.3106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348639PMC
March 2015

Endometrial stromal sarcoma: a clinicopathologic study of 29 patients.

J Reprod Med 2014 Nov-Dec;59(11-12):547-52

Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source
January 2015

Complications of pelvic radiation in patients treated for gynecologic malignancies.

Cancer 2014 Dec 23;120(24):3870-83. Epub 2014 Jul 23.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28849DOI Listing
December 2014

Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Int J Gynecol Pathol 2014 Nov;33(6):543-53

Division of Anatomic Pathology (R.J.Z., W.T.), Hershey Medical Center, Pennsylvania State University, Hershey, Pennysylvania Gynecologic Oncology Group Statistical and Data Center (W.E.B.), Buffalo, New York University of Iowa Med Center (K.L., M.I.), Iowa City, Iowa University of New Mexico (E.G.F.), Albuquerque, New Mexico Dana-Farber Partners Cancer Care Center, Brigham and Women's Hospital (an Affiliate of Fox Chase Cancer Center) (N.S.H.) Massachusetts General Hospital (L.R.D.), Dana-Farber Partners Cancer Care Center, (an Affiliate of Fox Chase Cancer Center), Boston, Massachusetts University of Oklahoma (R.S.M., J.L.W.), Oklahoma City, Oklahoma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533989PMC
November 2014

Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.

Gynecol Oncol 2014 Oct 1;135(1):54-7. Epub 2014 Aug 1.

Division of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.07.098DOI Listing
October 2014

What is the optimal treatment for obese patients with advanced ovarian carcinoma?

Am J Obstet Gynecol 2014 Sep 1;211(3):231.e1-9. Epub 2014 Apr 1.

Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2014.03.059DOI Listing
September 2014

Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.

Gynecol Oncol 2014 May 16;133(2):216-20. Epub 2014 Feb 16.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.02.011DOI Listing
May 2014

Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.

Gynecol Oncol 2014 Mar 16;132(3):760-6. Epub 2014 Jan 16.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.01.012DOI Listing
March 2014

A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.

Gynecol Oncol 2014 Jan 4;132(1):55-60. Epub 2013 Nov 4.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.10.031DOI Listing
January 2014

Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors.

Gynecol Oncol 2013 Nov 27;131(2):321-4. Epub 2013 Aug 27.

Division of Gynecologic Oncology, The University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.013DOI Listing
November 2013

Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182.

Gynecol Oncol 2013 Sep 17;130(3):487-92. Epub 2013 Jun 17.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.06.017DOI Listing
September 2013

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Int J Gynecol Cancer 2013 Sep;23(7):1219-25

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31829f17c9DOI Listing
September 2013

Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.

Gynecol Oncol 2013 Aug 23;130(2):312-6. Epub 2013 May 23.

Department of Gynecology and Obstetrics, Botucatu Medical School, UNESP-Sao Paulo State University, Botucatu, SP, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.05.017DOI Listing
August 2013

Prognostic determinants in patients with uterine and ovarian carcinosarcoma.

J Reprod Med 2013 Jul-Aug;58(7-8):297-304

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
August 2013

Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.

Gynecol Oncol 2013 Apr 18;129(1):63-8. Epub 2013 Jan 18.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258130001
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2013.01.009DOI Listing
April 2013

Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?

Gynecol Oncol 2013 Apr 31;129(1):69-73. Epub 2013 Jan 31.

Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.01.012DOI Listing
April 2013

Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.

Gynecol Oncol 2012 Oct 30;127(1):51-4. Epub 2012 May 30.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham & Women's Hospital, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258120039
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2012.05.026DOI Listing
October 2012

Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function.

J Psychosoc Oncol 2012 ;30(4):387-401

Harvard Medical School, Dana Farber Cancer Institute, Department of Gynecology Oncology, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07347332.2012.684854DOI Listing
September 2012

Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.

Int J Gynecol Pathol 2012 Jul;31(4):337-43

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e31823ff422DOI Listing
July 2012

A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.

J Reprod Med 2012 May-Jun;57(5-6):211-8

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New England Trophoblastic Disease Center, Trophoblastic Disease Registry, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
July 2012

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy.

Gynecol Oncol 2012 May 12;125(2):362-6. Epub 2012 Feb 12.

Brigham and Women's Hospital, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.02.006DOI Listing
May 2012

Prognostic determinants in patients with uterine and ovarian clear carcinoma.

Gynecol Oncol 2012 May 21;125(2):376-80. Epub 2012 Feb 21.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.02.016DOI Listing
May 2012

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.

Ann Surg Oncol 2012 Mar 13;19(3):959-65. Epub 2011 Oct 13.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-2100-xDOI Listing
March 2012

Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.

Int J Gynecol Cancer 2012 Mar;22(3):417-24

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31823c6e36DOI Listing
March 2012

New biologic agents for the treatment of gynecologic cancers.

Hematol Oncol Clin North Am 2012 Feb;26(1):133-56

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2011.11.002DOI Listing
February 2012

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study.

Gynecol Oncol 2012 Jan 26;124(1):53-8. Epub 2011 Oct 26.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.09.024DOI Listing
January 2012

Management of adnexal masses in pregnancy.

Authors:
Neil S Horowitz

Clin Obstet Gynecol 2011 Dec;54(4):519-27

Division of Gynecologic Oncology, Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0b013e318236c583DOI Listing
December 2011

Carcinosarcoma of the ovary: a case-control study.

Gynecol Oncol 2011 Jun 21;121(3):477-81. Epub 2011 Mar 21.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258110014
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2011.02.023DOI Listing
June 2011

Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.

Gynecol Oncol 2010 Nov 5;119(2):299-304. Epub 2010 Aug 5.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.07.010DOI Listing
November 2010